Retension Pharmaceuticals, Inc. Common Stock (RTSN) Price Prediction & Forecast

$10.720

-0.809 (-7.55%)At close

Price Predictions

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

Should I Buy Retension Pharmaceuticals, Inc. Common Stock Stock?

Retension Pharmaceuticals may not be a good buy right now due to its current price of $11.44, which is significantly below the analyst's target of $55, but the recent 5-day decline of 19.66% raises concerns about short-term performance. The company has reported negative net income in the last four quarters, with a loss of $4,170,589 in Q2 2026, indicating ongoing financial struggles.

RTSN stock price ended at $10.72 on Thursday, after losing -7.55%

Retension Pharmaceuticals, Inc. Common Stock (RTSN) last closed at $10.7200003, losing -7.55%. These facts feed the 1-day and 1-week RTSN price prediction above.

Forecast Drivers

Retension Pharmaceuticals, Inc. Common Stock (RTSN) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Seasonality

Negative

Bearish

Seasonality analysis for RTSN